6sense Enhances Go-To-Market Team Alignment, Names Latané Conant as Chief Revenue Officer
RevTech leader showcases outstanding results and momentum moving into final months of FY24 SAN FRANCISCO–(BUSINESS…
RevTech leader showcases outstanding results and momentum moving into final months of FY24 SAN FRANCISCO–(BUSINESS…
Powered by Green Dot’s Banking-as-a-Service Platform, Stockpile Will Offer Debit Cards with Parental Spending Controls…
Spin-off from Novartis successfully completed with first trading day today on SIX Swiss Exchange; Sandoz…
Popular social media company takes proactive step towards safeguarding sensitive customer data and intellectual property…
The pet food supplier saw an immediate drop in the amount of time spent answering…
AI-powered McAfee Scam Protection detects and protects against risky links in real-time and is now…
WASHINGTON–(BUSINESS WIRE)–The highly anticipated biennial conference of Procter & Gamble (P&G) alumni is set to…
If approved, odronextamab would be the first and only bispecific antibody approved in both FL…
If approved, odronextamab would be the first and only bispecific antibody approved in both FL…
AUSTIN, Texas–(BUSINESS WIRE)–Responsible AI Institute (RAI Institute), the non-profit enabling global organizations to harness the…
– Four abstracts highlight Gene Circuit platforms that enhance the scope, precision, effectiveness, and controllability…
– Four abstracts highlight Gene Circuit platforms that enhance the scope, precision, effectiveness, and controllability…
Independent global leaders in medical research on women’s health, Professor Amanda Black and Professor Wulf…
NEWS RELEASE September 26, 2023, 5:00PM EDT / 23:00 CET Mdxhealth Signs Research…
SOUTH SAN FRANCISCO, Calif., Sept. 26, 2023 (GLOBE NEWSWIRE) — Senti Biosciences, Inc. (Nasdaq: SNTI)…
Elevate Brings Together Thousands of HR & Benefits Professionals To Discuss The Most Pressing Topics…
TYSONS, Va.–(BUSINESS WIRE)–Red Cell Partners (Red Cell), an incubation firm building rapidly scalable, technology-led companies…
Reata acquisition bolsters Biogen’s rare disease portfolio with the addition of SKYCLARYS® (omaveloxolone), the first…
Reata acquisition bolsters Biogen’s rare disease portfolio with the addition of SKYCLARYS® (omaveloxolone), the first…
NEW YORK, Sept. 26, 2023 (GLOBE NEWSWIRE) — NetworkNewsAudio – Lucy Scientific Discovery (NASDAQ: LSDI) announces…